To access this element change to forms mode OFF
Grant Award View - GA142427-V2
Harnessing molecular strain for drug discovery and bioconjugation
GA ID:
GA142427-V2
Agency:
Australian Research Council
Approval Date:
11-Dec-2020
Variation Publish Date:
20-Oct-2021
Variation Date:
12-Oct-2021
Category:
Science, Technology, Engineering and Mathematics (STEM) Research
Grant Term:
1-Jan-2021 to 31-Dec-2023
Value (AUD):
$380,000.00
(GST inclusive where applicable)
Varies:
GA142427
- Harnessing molecular strain for drug discovery and bioconjugation
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
ARC 20/21 Discovery
Grant Program:
Discovery Projects
Grant Activity:
Harnessing molecular strain for drug discovery and bioconjugation
Purpose:
Peptides and proteins are increasingly important therapies for the treatment of disease. Nevertheless, the synthesis and optimisation of these high-value compounds still relies primarily on technologies developed decades ago. There is a desperate need for modern strategies to unlock the full potential of peptides and proteins for diverse applications in drug discovery. This interdisciplinary research aims to develop new tools for the construction and modification of peptides and proteins by harnessing the energy in a unique class of strained molecules. A focus on peptide-based inhibitors of the proteasome, a critical target for modern cancer treatments, should provide future health and economic benefits for the Australian community.
GO ID:
GO Title:
Discovery Projects for funding commencing in 2021
Internal Reference ID:
DP21 Round 1
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
The Australian National University
Recipient ABN:
52 234 063 906
Grant Recipient Location
Suburb:
ACTON
Town/City:
ACTON
Postcode:
2601
State/Territory:
ACT
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT
Postcode:
2601
Country:
AUSTRALIA